53. Abbott Laboratories 2012 ($1,499 million)
Abbott Laboratories pleaded guilty to misbranding epilepsy, bipolar disorder and migraine prevention drug Depakote in 2012, and paid US$1.5 billion in total.
To read more
Subscribe to Global Investigations Review
Subscribe and start reading now
Global Investigations Review (GIR) is the hub for global coverage of corporate investigations and their aftermath. Keep up to date with significant developments in the corporate investigations world.
Upgrade now